Fresenius Medical Care AG & Co. KGaA (FME.DE)
EUR 45.34
(1.86%)
EUR 45.34
(1.86%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.36 Billion EUR | 679.42% |
| 2022 | -258.36 Million EUR | -185.74% |
| 2021 | 301.32 Million EUR | -43.04% |
| 2020 | 529 Million EUR | -25.49% |
| 2019 | 710 Million EUR | -76.63% |
| 2018 | 3.03 Billion EUR | 28.62% |
| 2017 | 2.36 Billion EUR | -5.83% |
| 2016 | 2.5 Billion EUR | 17.85% |
| 2015 | 2.12 Billion EUR | 14.78% |
| 2014 | 1.85 Billion EUR | 13.5% |
| 2013 | 1.63 Billion EUR | -2.6% |
| 2012 | 1.67 Billion EUR | 4.79% |
| 2011 | 1.6 Billion EUR | 10.67% |
| 2010 | 1.44 Billion EUR | 18.05% |
| 2009 | 1.22 Billion EUR | 1.99% |
| 2008 | 1.2 Billion EUR | 10.85% |
| 2007 | 1.08 Billion EUR | 8.51% |
| 2006 | 998.73 Million EUR | 25.99% |
| 2005 | 792.73 Million EUR | 26.08% |
| 2004 | 628.75 Million EUR | 4.54% |
| 2003 | 601.42 Million EUR | -9.19% |
| 2002 | 662.28 Million EUR | 55.39% |
| 2001 | 426.2 Million EUR | -35.52% |
| 2000 | 661 Million EUR | 18.73% |
| 1999 | 556.73 Million EUR | 33.55% |
| 1998 | 416.86 Million EUR | -85.92% |
| 1997 | 2.96 Billion EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 474.91 Million EUR | 8.18% |
| 2024 Q3 | 350 Million EUR | 31.19% |
| 2024 Q2 | 352.69 Million EUR | -25.73% |
| 2023 Q4 | 439 Million EUR | 35.4% |
| 2023 Q2 | 356.62 Million EUR | 36.67% |
| 2023 Q3 | 324.22 Million EUR | -9.08% |
| 2023 Q1 | 260.93 Million EUR | 321.75% |
| 2023 FY | 1.49 Billion EUR | 679.42% |
| 2022 Q1 | 347.66 Million EUR | -22.57% |
| 2022 FY | -258.36 Million EUR | -185.74% |
| 2022 Q2 | 340.51 Million EUR | -2.06% |
| 2022 Q4 | -117.67 Million EUR | -124.95% |
| 2022 Q3 | 471.64 Million EUR | 38.51% |
| 2021 Q1 | 474.25 Million EUR | 2.65% |
| 2021 Q2 | 424.22 Million EUR | -10.55% |
| 2021 Q3 | 504.66 Million EUR | 18.96% |
| 2021 Q4 | 449 Million EUR | -11.03% |
| 2021 FY | 301.32 Million EUR | -43.04% |
| 2020 Q4 | 462 Million EUR | -26.87% |
| 2020 Q1 | 555.13 Million EUR | -9.88% |
| 2020 Q2 | 656 Million EUR | 18.17% |
| 2020 Q3 | 631.78 Million EUR | -3.69% |
| 2020 FY | 529 Million EUR | -25.49% |
| 2019 Q2 | 521.25 Million EUR | -2.85% |
| 2019 Q4 | 616 Million EUR | 3.46% |
| 2019 Q3 | 595.38 Million EUR | 14.22% |
| 2019 FY | 710 Million EUR | -76.63% |
| 2019 Q1 | 536.55 Million EUR | -12.47% |
| 2018 Q3 | 526.72 Million EUR | -62.41% |
| 2018 Q2 | 1.4 Billion EUR | 181.91% |
| 2018 Q1 | 497 Million EUR | -4.24% |
| 2018 Q4 | 613 Million EUR | 16.38% |
| 2018 FY | 3.03 Billion EUR | 28.62% |
| 2017 Q3 | 608.58 Million EUR | 4.33% |
| 2017 FY | 2.36 Billion EUR | -5.83% |
| 2017 Q4 | 519 Million EUR | -14.72% |
| 2017 Q2 | 583.3 Million EUR | -10.44% |
| 2017 Q1 | 651.27 Million EUR | -12.86% |
| 2016 Q1 | 476.73 Million EUR | -21.27% |
| 2016 Q4 | 747.36 Million EUR | 25.15% |
| 2016 Q3 | 597.15 Million EUR | 3.61% |
| 2016 Q2 | 576.34 Million EUR | 20.9% |
| 2016 FY | 2.5 Billion EUR | 17.85% |
| 2015 Q3 | 545.26 Million EUR | 11.81% |
| 2015 FY | 2.12 Billion EUR | 14.78% |
| 2015 Q2 | 487.66 Million EUR | 4.7% |
| 2015 Q1 | 465.77 Million EUR | -14.57% |
| 2015 Q4 | 605.5 Million EUR | 11.05% |
| 2014 Q1 | 323.48 Million EUR | -28.44% |
| 2014 Q4 | 545.22 Million EUR | 17.28% |
| 2014 FY | 1.85 Billion EUR | 13.5% |
| 2014 Q2 | 407.73 Million EUR | 26.05% |
| 2014 Q3 | 464.9 Million EUR | 14.02% |
| 2013 Q2 | 418.32 Million EUR | 8.59% |
| 2013 Q1 | 385.21 Million EUR | 0.01% |
| 2013 FY | 1.63 Billion EUR | -2.6% |
| 2013 Q4 | 452.02 Million EUR | 9.46% |
| 2013 Q3 | 412.96 Million EUR | -1.28% |
| 2012 Q4 | 385.16 Million EUR | -12.87% |
| 2012 FY | 1.67 Billion EUR | 4.79% |
| 2012 Q1 | 377.03 Million EUR | -25.34% |
| 2012 Q2 | 465.1 Million EUR | 23.36% |
| 2012 Q3 | 442.08 Million EUR | -4.95% |
| 2011 FY | 1.6 Billion EUR | 10.67% |
| 2011 Q4 | 505.03 Million EUR | 28.51% |
| 2011 Q3 | 392.97 Million EUR | 11.65% |
| 2011 Q2 | 351.96 Million EUR | 11.65% |
| 2011 Q1 | 315.23 Million EUR | -26.73% |
| 2010 Q3 | 361.93 Million EUR | -5.09% |
| 2010 Q1 | 315.45 Million EUR | -12.76% |
| 2010 Q2 | 381.35 Million EUR | 20.89% |
| 2010 FY | 1.44 Billion EUR | 18.05% |
| 2010 Q4 | 430.22 Million EUR | 18.87% |
| 2009 Q2 | 297.67 Million EUR | -0.23% |
| 2009 Q3 | 308.2 Million EUR | 3.54% |
| 2009 Q4 | 361.6 Million EUR | 17.32% |
| 2009 FY | 1.22 Billion EUR | 1.99% |
| 2009 Q1 | 298.36 Million EUR | -7.32% |
| 2008 Q2 | 272.63 Million EUR | 10.78% |
| 2008 FY | 1.2 Billion EUR | 10.85% |
| 2008 Q4 | 321.94 Million EUR | 7.51% |
| 2008 Q3 | 299.44 Million EUR | 9.83% |
| 2008 Q1 | 246.1 Million EUR | -10.88% |
| 2007 Q3 | 278 Million EUR | -3.77% |
| 2007 Q2 | 288.89 Million EUR | 5.83% |
| 2007 FY | 1.08 Billion EUR | 8.51% |
| 2007 Q1 | 272.99 Million EUR | 14.32% |
| 2007 Q4 | 276.15 Million EUR | -0.67% |
| 2006 Q2 | 290.95 Million EUR | 44.63% |
| 2006 Q4 | 238.8 Million EUR | -13.11% |
| 2006 FY | 998.73 Million EUR | 25.99% |
| 2006 Q3 | 274.84 Million EUR | -5.54% |
| 2006 Q1 | 201.17 Million EUR | -6.43% |
| 2005 FY | 792.73 Million EUR | 26.08% |
| 2005 Q4 | 215 Million EUR | 9.16% |
| 2005 Q3 | 196.97 Million EUR | 0.16% |
| 2005 Q2 | 196.65 Million EUR | 15.88% |
| 2005 Q1 | 169.7 Million EUR | 34.46% |
| 2004 FY | 628.75 Million EUR | 4.54% |
| 2004 Q4 | 126.2 Million EUR | -26.68% |
| 2004 Q2 | 174.36 Million EUR | 8.39% |
| 2004 Q3 | 172.13 Million EUR | -1.27% |
| 2004 Q1 | 160.86 Million EUR | 23.91% |
| 2003 Q2 | 159.78 Million EUR | 3.41% |
| 2003 Q1 | 154.52 Million EUR | 6.61% |
| 2003 FY | 601.42 Million EUR | -9.19% |
| 2003 Q4 | 129.82 Million EUR | -23.2% |
| 2003 Q3 | 169.05 Million EUR | 5.8% |
| 2002 Q2 | 171.54 Million EUR | -14.02% |
| 2002 Q3 | 168.66 Million EUR | -1.68% |
| 2002 Q4 | 144.94 Million EUR | -14.06% |
| 2002 FY | 662.28 Million EUR | 55.39% |
| 2002 Q1 | 199.5 Million EUR | 287.05% |
| 2001 FY | 426.2 Million EUR | -35.52% |
| 2001 Q4 | -106.66 Million EUR | -159.79% |
| 2001 Q3 | 178.38 Million EUR | -8.46% |
| 2001 Q2 | 194.86 Million EUR | 8.51% |
| 2001 Q1 | 179.58 Million EUR | 37.33% |
| 2000 FY | 661 Million EUR | 18.73% |
| 2000 Q4 | 130.76 Million EUR | -31.0% |
| 2000 Q3 | 189.52 Million EUR | 16.43% |
| 2000 Q2 | 162.78 Million EUR | 6.95% |
| 2000 Q1 | 152.2 Million EUR | 107.12% |
| 1999 Q1 | 891.88 Million EUR | 150.23% |
| 1999 Q2 | 927.36 Million EUR | 3.98% |
| 1999 Q3 | 897.96 Million EUR | -3.17% |
| 1999 Q4 | -2.13 Billion EUR | -338.0% |
| 1999 FY | 556.73 Million EUR | 33.55% |
| 1998 Q3 | 755.45 Million EUR | -4.93% |
| 1998 FY | 416.86 Million EUR | -85.92% |
| 1998 Q1 | 819.87 Million EUR | 1.07% |
| 1998 Q4 | -1.77 Billion EUR | -335.05% |
| 1998 Q2 | 794.62 Million EUR | -3.08% |
| 1997 Q4 | 811.18 Million EUR | 12.16% |
| 1997 Q2 | 702.26 Million EUR | 2.99% |
| 1997 FY | 2.96 Billion EUR | 0.0% |
| 1997 Q1 | 681.89 Million EUR | 0.0% |
| 1997 Q3 | 723.21 Million EUR | 2.98% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Fresenius SE & Co. KGaA | 1.14 Billion EUR | -19.811% |
| LIMES Schlosskliniken AG | 5.02 Million EUR | -27147.677% |
| M1 Kliniken AG | 15.69 Million EUR | -8622.597% |
| Maternus-Kliniken Aktiengesellschaft | -9.26 Million EUR | 14888.747% |
| MEDICLIN Aktiengesellschaft | 12.72 Million EUR | -10664.52% |
| RHÖN-KLINIKUM Aktiengesellschaft | 40.39 Million EUR | -3289.782% |
| VITA 34 AG | -3.12 Million EUR | 43992.244% |